{
    "ticker": "ETNB",
    "name": "Eton Pharmaceuticals, Inc.",
    "description": "Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative products for the pediatric population. Founded in 2017 and headquartered in Deer Park, Illinois, Eton is dedicated to addressing the unique needs of children who often require different dosages and formulations than adults. The company develops a portfolio of proprietary product candidates, including the first FDA-approved liquid formulation of the anticonvulsant drug, which aims to improve accessibility and adherence to treatment in children with epilepsy. Eton's commitment to the pediatric population extends to various therapeutic areas, including pain management, oncology, and infectious diseases. By leveraging a robust pipeline and strategic partnerships, Eton seeks to enhance the quality of life for children and their families through innovative pharmaceutical solutions. The company is also focused on advancing its proprietary formulation technologies, which can be applied to create better versions of existing medications. With a mission to transform pediatric care, Eton Pharmaceuticals continues to strive for breakthroughs that address unmet medical needs in the healthcare industry.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Deer Park, Illinois, USA",
    "founded": "2017",
    "website": "https://etonpharma.com",
    "ceo": "Sean O'Connor",
    "social_media": {
        "twitter": "https://twitter.com/EtonPharma",
        "linkedin": "https://www.linkedin.com/company/eton-pharmaceuticals/"
    },
    "investor_relations": "https://etonpharma.com/investors",
    "key_executives": [
        {
            "name": "Sean O'Connor",
            "position": "CEO"
        },
        {
            "name": "Michael McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pediatric Pharmaceuticals",
            "products": [
                "FDA-approved liquid formulations",
                "Anticonvulsants",
                "Pain management solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Eton Pharmaceuticals, Inc. | Innovative Pediatric Pharmaceuticals",
        "meta_description": "Eton Pharmaceuticals is dedicated to developing innovative pharmaceutical solutions for the pediatric population, addressing unique medical needs and enhancing quality of life.",
        "keywords": [
            "Eton Pharmaceuticals",
            "Pediatric Pharmaceuticals",
            "Innovative Treatments",
            "Anticonvulsants",
            "Specialty Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What does Eton Pharmaceuticals specialize in?",
            "answer": "Eton Pharmaceuticals specializes in developing and commercializing innovative products for the pediatric population."
        },
        {
            "question": "When was Eton Pharmaceuticals founded?",
            "answer": "Eton Pharmaceuticals was founded in 2017."
        },
        {
            "question": "Where is Eton Pharmaceuticals headquartered?",
            "answer": "Eton Pharmaceuticals is headquartered in Deer Park, Illinois, USA."
        },
        {
            "question": "What types of products does Eton develop?",
            "answer": "Eton develops pediatric pharmaceuticals including FDA-approved liquid formulations and pain management solutions."
        }
    ],
    "competitors": [
        "RMD",
        "PFE",
        "MRNA",
        "VRTX"
    ],
    "related_stocks": [
        "JNJ",
        "ABBV",
        "AMGN",
        "BMY"
    ]
}